Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.35 |
| ▸ | GAA | P10253 | 4/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | GFER | P55789 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 4/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6167985 | 0.78 | MAPT (0.42) | MAPTGAAKMT2AKDM4EALDH1A1 | |
| SCHEMBL8009756 | 0.73 | KDM4E (0.42) | MAPTGAAKMT2AKDM4EALDH1A1 | |
| SCHEMBL40368 | 0.71 | CYP2C9 (0.55) | MAPTGAAKMT2AALDH1A1HSD17B10 | |
| SCHEMBL7546321 | 0.69 | CYP2C9 (0.34) | MAPTGAAKMT2AALDH1A1HSD17B10 | |
| SCHEMBL4583348 | 0.68 | LMNA (0.46) | MAPTGAAKMT2AALDH1A1HSD17B10 | |
| SCHEMBL6241456 | 0.67 | CYP2C9 (0.42) | MAPTGAAKMT2AKDM4EALDH1A1 | |
| SCHEMBL25949524 | 0.67 | CYP2C9 (0.42) | MAPTKMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL12203849 | 0.66 | TAAR1 (0.42) | MAPTGAAKMT2AKDM4EALDH1A1 | |
| SCHEMBL10951188 | 0.65 | HTR2A (0.33) | CYP2C9NISCHMAOAMAOB | |
| SCHEMBL27927654 | 0.65 | CYP2C9 (0.49) | MAPTGAAKMT2AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3053963-A1 | HALOGEN-FREE RESIN COMPOSITION AND USE THEREOF | Shengyi Technology Co. Ltd. (CN) | 2016-08-10 | — | — | EP | disclosed |
| US-20140072800-A1 | COATED ARTICLE COMPRISING A CURABLE COMPOSITION COMPRISING BIS-BENZOXAZINE AND AN AMINO-FUNCTIONALIZED TRIAZINE | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-03-13 | — | — | US | disclosed |
| US-20140073736-A1 | CURABLE COMPOSITION COMPRISING BIS-BENZOXAZINE, METHOD OF CURING, AND THE CURED COMPOSITION SO FORMED | E I DU PONT NEMOURS AND COMPANY (US) | 2014-03-13 | — | — | US | disclosed |
| US-20140069693-A1 | MULTI-LAYER ARTICLE COMPRISING DISCRETE CONDUCTIVE PATHWAYS CONTACTING A CURABLE COMPOSITION COMPRISING BIS-BENZOXAZINE | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-03-13 | — | — | US | disclosed |
| US-20110152453-A1 | Benzoxazine Compounds Derivated From Phenolphtalein Having Flame-Retardant Properties And A Process For Their Preparation | HUNTSMAN ADVANCED MATERIALS AMERICAS INC. (US) | 2011-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110152453-A1 | Benzoxazine Compounds Derivated From Phenolphtalein Having Flame-Retardant Properties And A Process For Their Preparation | HPD, PAH, BRPF3 | MAPT 1000/4885GAA 3518/4885KMT2A 806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.